Effects of promethazine and altered gravity on bimanual coordination

Status

Completed

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504256-10-00

Acronym

BMC in AG

Enrollment

Registered

2023-06-02

Start date

2023-06-10

Completion date

2023-06-15

Last updated

2023-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Brief summary

Bimanual coordination performance, assessed by the harmonicity

Interventions

DRUGcomprimé enrobe.

DRUGComprimé placebo à usage thérapeutique commercialisé par centrelab sous la référence f00199. Composition : - hydrogénophosphate de calcium dihydraté : 244

DRUG4 mg - amidon de maïs : 13 mg - stéarate de magnésium : 2

DRUG6 mg

DRUGPHENERGAN 25 mg

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Bimanual coordination performance, assessed by the harmonicity	—

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026